Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
09/20/2001
Lexicon Genetics and Deltagen Announce Settlement of Patent Infringement Litigation
08/23/2001
Lexicon Genetics Licenses Patented Gene Targeting Technology To Merck & Co., Inc.
08/21/2001
Lexicon Genetics Announces Key Scientific Leadership for High-Throughput Screening and Medicinal Chemistry
08/15/2001
Lexicon Genetics Grants Patented Gene Targeting Technology License To GlaxoSmithKline
08/14/2001
Lexicon Genetics Has Altered More Than One-Half of the Genes in the Mouse Genome
08/08/2001
Bristol-Myers Squibb Selects Pharmaceutically Relevant Targets for Drug Discovery From Lexicon's LexVision(TM) Database
08/07/2001
Lexicon Genetics Reports Second Quarter 2001 Financial Results
07/31/2001
Lexicon Genetics Signs Drug Target Validation Agreement With Immunex Corporation
07/30/2001
Lexicon Genetics Announces Webcast to Discuss Second Quarter 2001 Financial Results
07/26/2001
Lexicon Genetics Expands OmniBank(R) Universal Agreement With Organon
«
Start
Prev
31
32
33
34
35
36
37
38
39
40
Next
End
»
Page 34 of 41
